marijuana as medicine
play

Marijuana as Medicine: Unintended Consequences and Concerns David - PowerPoint PPT Presentation

Marijuana as Medicine: Unintended Consequences and Concerns David R. Reagan, MD PhD | Chief Medical Officer | September 13, 2017 Michael D. Warren, MD MPH | Deputy Commissioner for Population Health | September 13, 2017 Disclosures David


  1. Marijuana as Medicine: Unintended Consequences and Concerns David R. Reagan, MD PhD | Chief Medical Officer | September 13, 2017 Michael D. Warren, MD MPH | Deputy Commissioner for Population Health | September 13, 2017

  2. Disclosures • David Reagan, MD PhD, has disclosed no actual, potential, or perceived conflicts of interest. • Michael Warren, MD MPH, has disclosed no actual, potential, or perceived conflicts of interest.

  3. Objectives • Describe the current policy landscape related to the use of marijuana as medicine. • Identify the individual benefits associated with use of marijuana as medicine. • Outline the population harms associated with use of marijuana as medicine.

  4. Background

  5. Marijuana: The Basics • Produced from Cannabis sativa • DEA Schedule I Drug – No currently accepted use of whole plant • (There are FDA-approved meds) – High potential for abuse • Available (non-pharmaceutical grade) forms: – Cigarette/blunt/pipe/bong – Edibles – Tea/brew Image sources: 1. Cannabis plant: https://www.dea.gov/druginfo/ds.shtml 2. Cannabis and joint: NIDA, https://www.drugabuse.gov/publications/drugfacts/marijuana 3. Marijuana Cookie: By Subvertc - Own work, CC BY-SA 3.0, https://commons.wikimedia.org/w/index.php?curid=18683918

  6. Marijuana: The Basics • Three main “types” • Determined by enzyme concentration • 0.5-15% THC • “Drug” type THC Type • 0.05-0.7% THC • Fiber / hemp / oil type CBD Type • 0.5-5% THC Hybrid type Source: National Academy of Sciences. https://www.nap.edu/catalog/24625/the-health-effects-of-cannabis-and-cannabinoids-the- current-state

  7. Marijuana: The Basics Delta-9-tetrahydrocannabinol (  -9-THC) • – Compound responsible for psychoactive effects – Time to onset of effect and duration of effect depends on method of ingestion • Typical effects – Euphoria – Disinhibition, increased sociability – Enhanced sensory perception – Time distortion • Adverse effects – Typical: Impaired judgment, reduced coordination, dry mouth, anxiety, fear, distrust, panic – Others: cyclic vomiting, stress cardiomyopathy

  8. Marijuana: The Basics • Even with approved medications, one person’s “desired effects” may be another person’s “adverse effects” Elation Some patients Adverse event experience “high” Laughing among 24% at Heightened anti-emetic dose Awareness and 8% at appetite stimulant dose Source: US Food and Drug Administration. Available at: https://www.fda.gov/ohrms/dockets/dockets/05n0479/05N-0479-emc0004-04.pdf

  9. From opium poppy to oxycodone… Source for images: Drug Enforcement Administration Museum and Visitors Center. Available at: https://www.deamuseum.org/ccp/opium/history.html. Last accessed 04/13/2017.

  10. From mold to penicillin tablets and liquid… Image sources: 1. Penicillin mold: https://commons.wikimedia.org/wiki/File:Penicillium_notatum.jpg. 2. Penicillin tablets: https://www.drugs.com/pro/penicillin-vk.html 3. Penicillin oral solution label: https://www.drugs.com/pro/penicillin-v.html

  11. From foxglove to digitalis… Image sources: 1. Foxglove botanical print: By Walther Otto Müller - http://caliban.mpiz-koeln.mpg.de/koehler/DIGITALIS.jpg, Public Domain, https://commons.wikimedia.org/w/index.php?curid=1815791 2. Dioxin label: https://www.drugs.com/pro/digox-tablets.html 3. Digoxin tablets: https://www.drugs.com/digoxin.html

  12. From marijuana to medicine… • Current FDA-approved cannabinoid- based medications – Dronabinol (Marinol) — synthetic THC • Nausea/vomiting in chemotherapy patients • Appetite stimulation in AIDS patients – Nabilone (Cesamet) — synthetic THC • Multiple sclerosis • Adjunctive analgesic in cancer patients • Pending approval – Epidiolex (>98% CBD) – Nabiximol (Sativex, 1:1 THC/CBD) • FDA approval and pharmaceutical-grade manufacturing process assures safety , efficacy , quality , and consistency

  13. Marijuana Intoxication & Use Disorder Use/Intoxication Substance Use Disorder Mild: 2-3 Symptoms Moderate: 4-5 symptoms Severe: 6+ symptoms Withdrawal can occur after heavy/prolonged use Reversible Self-Harm Source: American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition. Arlington, VA, American Psychiatric Association, 2013.

  14. A Common Pathway: Dopamine Many Drugs Lead to Dopamine Release • Amphetamines, Cocaine, Opioids, Nicotine, Sedatives, Marijuana, Ethanol With increased dopamine: • Dopamine receptors are decreased • Equilibrium is re-established • When dopamine decreases, the number of receptors remains less • Normal dopamine levels feel low • Takes months or years to restore normal balance MAO – Monoamine oxidase (inactivates DA) VMAT2 – Vesicular monoamine transporter 2 DAT – Dopamine uptake transporter D1 – D5 – Dopamine receptors

  15. Current Policy Landscape

  16. State Marijuana Laws: Current Landscape Source: National Conference of State Legislatures. Deep Dive: Marijuana. Available at: http://www.ncsl.org/bookstore/state- legislatures-magazine/marijuana-deep-dive.aspx. Last accessed 08/13/2017.

  17. Current TN Laws • Tennessee Code Annotated § 39-17-402 – Defines “marijuana” – Does not include industrial hemp – Allowances for cannabidiol products as approved by FDA or in case of intractable seizures

  18. Medical Marijuana: Public Health Concerns The population The individual harms of Medical benefits of marijuana as marijuana is not marijuana as medicine have a solution to the medicine have opioid crisis. been been overstated. understated.

  19. Individual Benefits of Marijuana as Medicine

  20. Marijuana: Individual Benefits OVERstated • Most comprehensive review to date by National Academy of Sciences in 2017 – 22 conclusions re: therapeutic benefits, only 3 with “substantial or conclusive evidence” of benefit • Spasticity due to multiple sclerosis • Chemotherapy-induced nausea/vomiting • Chronic [neuropathic] pain – 4 conclusions with substantial evidence of harm: • Worsening respiratory symptoms and frequent chronic bronchitis •  risk of motor vehicle crashes • Lower birth weight of offspring • Development of schizophrenia or other psychoses Image source: National Academy of Sciences. https://www.nap.edu/catalog/24625/the-health-effects-of-cannabis-and-cannabinoids- the-current-state

  21. Marijuana: Individual Benefits OVERstated • Not a lack of information on this topic – What can be trusted? – Who benefits? • Quality of available information varies widely – Study type – Publication source – Peer review status Image source: Wake Forest School of Medicine. Available at: http://libguides.wakehealth.edu/EBP/Study. Last accessed 02/08/2017

  22. Marijuana: Individual Benefits OVERstated Helen of Troy “The Face That Launched 1,000 Ships” Article: Porter J, Jick H. Addiction rare in patients treated with narcotics. New England Journal of Medicine. 1980; 302:123 Image: By Evelyn de Morgan - Secondary source: http://en.wikipedia.org/wiki/Image:Helen_of_Troy.jpg, Public Domain, https://commons.wikimedia.org/w/index.php?curid=160766

  23. Marijuana: Individual Benefits OVERstated • Study funded by pharmaceutical company • “ Open- label”  not blinded, large potential for placebo effect • Patients had treatment-resistant epilepsy (e.g. Lennox-Gastaut and Dravet syndromes) • 12% of patients had adverse events related to cannabidiol • Conclusion: Need randomized controlled trial Devinski O et al. Cannabidiol in patients with treatment-resistant epilepsy: an open-label interventional trial. Lancet Neurology. 2016; 15: 270-78.

  24. Population Harms of Marijuana as Medicine

  25. Marijuana: Population Harms UNDERstated Average Delta-9-THC concentration of DEA Specimens by Year, 1995-2014 Source: ElSohly MA, Mehmedic Z, Foster S, Gon C, Chandra S, Church JC. Changes in Cannabis Potency over the Last Two Decades (1995-2014) - Analysis of Current Data in the United States. Biological Psychiatry. 2016. April 1; 79(7): 613 – 619.

  26. WA: Marijuana-related impaired driving Source: WA data and image: Washington State Marijuana Impact Report. Available at: https://hidtanmi.org/2016/07/01/northwest-hidta- washington-impact-report/. Last accessed 04/12/2017.

  27. CO: Marijuana-related impaired driving Source: Rocky Mountain High Intensity Drug Trafficking Area. The Legalization of Marijuana in Colorado: The Impact. Volume 4, September 2016. Available at: http://www.rmhidta.org/html/2016 FINAL Legalization of Marijuana in Colorado The Impact.pdf. Last accessed 04/20/2017.

  28. Marijuana: Population Harms UNDERstated Image sources: https://www.childrenscolorado.org/conditions-and-advice/marijuana-what-parents-need-to-know/resources/

  29. Marijuana: Population Harms UNDERstated Sources: 1. Wang GS, Le Lait MC, Deakyne SJ, Bronstein AC, Bajaja L, Roosevelt G. Unintentional Pediatric Exposures to Marijuana in Colorado, 2009-2015. JAMA Pediatrics. 2016;170(9):e160971. 2. Wang GS, Roosevelt G, Heard K. Pediatric Marijuana Exposures in a Medical Marijuana State. JAMA Pediatrics. 2013;167(7):630-633.

Download Presentation
Download Policy: The content available on the website is offered to you 'AS IS' for your personal information and use only. It cannot be commercialized, licensed, or distributed on other websites without prior consent from the author. To download a presentation, simply click this link. If you encounter any difficulties during the download process, it's possible that the publisher has removed the file from their server.

Recommend


More recommend